Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent method reduces solvent use and enhances purity for Carbenoxolone manufacturing ensuring supply chain stability and cost efficiency.
Novel FeCl3-catalyzed nitro reduction for Relugolix intermediates eliminates palladium residues, ensuring high purity and cost-effective manufacturing for global supply chains.
Patent CN105461606B details enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de value and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102181498B enzyme method ensures high purity omega-3 phosphatidylcholine with low pollution and scalable production for global nutritional ingredients suppliers.
Patent CN118515585A reveals metal-free alkenyl cyanide synthesis. High yield, trans-selective. Reliable supplier for pharma intermediates.
Patent CN102267913B reveals a safer TS-1 catalyzed route for 2,3-dimethyl-2,3-dinitrobutane. Eliminate toxic nitropropane precursors for high-purity explosive tracers.
Patent CN101045936B details a novel enzymatic resolution process using succinic anhydride, offering significant cost reduction and simplified purification for pharmaceutical intermediates.
Patent CN104726504B enables eco-friendly enzymatic production. Offers high purity intermediates for pharmaceutical applications with simplified supply chain.
Patent CN116836141A reveals a novel Bempedoic Acid intermediate synthesis route offering high yield, purity, and scalable industrial production capabilities for global supply chains.
Patent CN101880241A reveals a safer one-pot Curtius rearrangement for Candesartan intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel patent CN104230880A enables cost-effective Atorvastatin side chain production. Reliable supplier for pharmaceutical intermediates with scalable green chemistry.
Advanced phase transfer catalysis for isoflavone 7-O-glucosides. Delivers high yields, mild conditions, and scalable production for global supply chains.
Patent CN116396207B reveals cost-effective photo-nickel catalysis for nitrogen heterocycles. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates significantly.
Patent CN113651684B reveals a safe, scalable iron-catalyzed oxidation route for 4-hydroxy-2-butynoic acid, offering significant cost reduction in API manufacturing.
Novel dual-acid catalysis method for cyclamen aldehyde production. High purity, reduced waste, scalable production for fragrance industry supply chain efficiency.
Novel 5,5'-linked biphenyl ligand patent CN103524557B offers high enantioselectivity for API manufacturing and supply chain reliability for global buyers seeking partners.
Patent CN112876401A discloses a mild, one-step iridium-catalyzed synthesis of chiral 3-allylindoles with high enantioselectivity, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN110845410B reveals a safe one-pot method for 6,7-dimethoxy-3,4-dihydroisoquinoline HCl using phosphotungstic acid, offering high purity and cost reduction.
Patent CN117486854B reveals one-pot thiophene synthesis. High yield solid super alkali catalyst reduces cost and pollution for OLED material supply chains.
Novel synthesis method for Rosuvastatin calcium key chiral intermediate. Avoids expensive raw materials, improves ee value, suitable for industrial scale-up and cost reduction.